Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Shorla Pharma Limited: Shorla Pharma Expands into the U.S. with the Opening of a Cambridge, MA Office
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Shorla Pharma Limited: Shorla Pharma Announces FDA Filing Acceptance and Priority Review for T-cell Leukemia Treatment
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Shorla Pharma Limited: Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer
Nicholas Holsman will lead commercialization of novel oncology products Shorla Pharma Limited ( Shorla ), a specialty pharmaceutical company, announces the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry executive with in-depth experience in scaling oncology specialty pharma enterprises.
Shorla specializes in developing innovative oncology drugs, with a focus on orphan and pediatric cancers. With a strong team of scientists, clinicians and an extensive industry network, the company has an advanced pipeline of drug products to treat a number of unmet patient needs.